Healthcare - Biotechnology - NASDAQ - NL
$ 3.82
-3.29 %
$ 394 M
Market Cap
-12.32
P/E
CASH FLOW STATEMENT
21.1 M
OPERATING CASH FLOW
4.19 M
INVESTING CASH FLOW
-2.28 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
ProQR Therapeutics N.V.
| Net Income | -27.5 M |
| Depreciation & Amortization | 2.46 M |
| Capital Expenditures | -3.65 M |
| Stock-Based Compensation | 3.11 M |
| Change in Working Capital | 49 M |
| Others | 43.6 M |
| Free Cash Flow | 17.5 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | (27.5) | (64.9) | (61.7) | (46.6) | (56.7) | (37.1) | (43.5) | (39.1) | (20.8) | (12.1) | (3.3) |
| Depreciation & Amortization | 2.5 | 2.5 | 2.3 | 2.4 | 2.1 | 1.0 | 1.1 | 1.2 | 0.5 | 0.1 | 24 K |
| Deferred Income Tax | 78 K | 96 K | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.2 | 0.4 | 0.1 | 13 K |
| Stock Based Compensation | 3.1 | 2.9 | 6.2 | 7.8 | 9.1 | 3.2 | 4.0 | 2.5 | 1.2 | 0.6 | 41 K |
| Other Operating Activities | (5.4) | (3.7) | 2.0 | (5.8) | (0.4) | 0.8 | 3.2 | (0.5) | (6.2) | (4.3) | 14 K |
| Change in Working Capital | 49.0 | (5.4) | 25.0 | (5.0) | 1.8 | 1.3 | 0.2 | 1.4 | 0.6 | 1.1 | 0.8 |
| Cash From Operations | 21.5 | (68.5) | (26.0) | (47.1) | (44.0) | (30.7) | (35.0) | (34.2) | (24.2) | (14.5) | (2.3) |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | (3.6) | (0.7) | (0.5) | (0.9) | (0.6) | (0.3) | (0.1) | (2.5) | (1.3) | (1.2) | (0.1) |
| Other Items | 7.8 | 6 K | 59 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 4.2 | (0.7) | (0.4) | (0.9) | (0.6) | (0.3) | (0.1) | (2.5) | (1.3) | (1.2) | (0.1) |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (2.6) | (45.0) | 26.8 | 13.8 | 1.5 | 1.4 | 1.0 | 0.4 | 1.6 | 1.6 | 3.3 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.4 | 34 K | 1.5 | 0.7 | 0.2 | 0.9 | 4 K | 2 K | 14 K | 0 | 0 |
| Cash From Financing Activities | (2.3) | (30.9) | 136.8 | 14.5 | 50.2 | 88.6 | 26.6 | 0.4 | 1.6 | 119.9 | 6.3 |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | 24.5 | (92.7) | 111.7 | (36.1) | 6.4 | 57.5 | (11.1) | (35.7) | (17.9) | 108.6 | 3.9 |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | 17.5 | (69.2) | (26.5) | (48.0) | (44.5) | (31.0) | (35.1) | (36.8) | (25.6) | (15.7) | (2.5) |